Table 3.
General characteristics and laboratory testing results in COVID-19 patients according to calcifediol supplementation. Values are expressed as mean value (±SD). BMI: Body Mass Index; RCP: reactive C protein; LDH: lactate dehydrogenase; INR: international normalized ratio; 25OHD: 25-hydroxy vitamin D; SpO2/FiO2: ratio of oxygen saturation/fraction of inspired oxygen; PaO2/FiO2: ratio of arterial oxygen partial pressure/fraction of inspired oxygen.
| Characteristics | Treated with Calcifediol (n = 56) |
Not Treated with Calcifediol (n = 232) |
p-Value |
|---|---|---|---|
| Age (years) | 71.8 (±16.4) | 74.9 (±13.4) | 0.1 |
| BMI | 29.2 (±11.5) | 26.7 (±4.1) | 0.008 |
| Number of comorbidities | 1.6 (±1.29) | 1.6 (±1.24) | >0.9 |
| CRP (mg/dL) | 9.8 (±7.6) | 8.6 (±7.2) | 0.3 |
| LDH (mU/mL) | 323.2 (±148.5) | 305 (±119.4) | 0.3 |
| D-dimer (ng/mL) | 3812 (±8174) | 3601 (±7438) | 0.8 |
| INR ratio | 1.32 (±0.6) | 1.23 (±1.23) | 0.6 |
| Lymphocytes (103/L) | 1.01 (±0.9) | 1 (±0.7) | 0.4 |
| 25OHD (ng/mL) | 17.3 (±11.4) | 18.9 (±14.3) | 0.4 |
| SpO2/FiO2 | 314.8 (±126.3) | 333.3 (±121.3) | 0.3 |
| PaO2/FiO2 | 247.6 (±111.7) | 239.6 (±90.9) | 0.6 |